| Literature DB >> 22478855 |
Mari Edlin, Peter Sonnenreich.
Abstract
The entry of oral medications for multiple sclerosis into the marketplace and the high cost of biologic drugs are presenting new challenges for stakeholders.Entities:
Year: 2011 PMID: 22478855 PMCID: PMC3138383
Source DB: PubMed Journal: Biotechnol Healthc ISSN: 1554-169X